#aod9604 AOD-9604 | CAS#221231-10-3 tested materials for laboratory and scientific research applications. AOD-9604

Though anecdotal reports are common, large-scale human trials remain limited, highlighting the need for further scientific validation

5-Amino-1MQ blocks the NNMT node to favor salvage flux [13]

Status Not FDA-approved

Lipogenesis Inhibition In adipocyte models, 5-Amino-1MQ suppresses lipogenesis (EC50 = 30 M in 3T3-L1 adipocytes) while increasing intracellular NAD+ concentrations

It is studied in metabolic research models for its effects on adipocyte energy expenditure and lipid metabolism

Note: Compounded medications are prepared based on specific patient needs or in the event of drug shortages and are not reviewed or approved by the FDA for safety or effectiveness